doi.org/10.1101/2020.07.09.20141762; this version posted July 10, 2020. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
It is made available under a CC-BY-NC-ND 4.0 International license.
Data Availability
Test count data is collected by the Covid Tracking Project9. For each state, we set the population N
according to the 2019 state population estimates projected from the 2010 US Census10.
References
[1] Ottar N Bj√∏rnstad, Katriona Shea, Martin Krzywinski, and Naomi Altman. Modeling infectious epi-
demics. Nature methods, 2020.
[2] EranBendavid,BiancaMulaney,NeerajSood,SoleilShah,EmiliaLing,RebeccaBromley-Dulfano,Cara
Lai, Zoe Weissberg, Rodrigo Saavedra, James Tedrow, et al. Covid-19 antibody seroprevalence in santa
clara county, california. medRxiv, 2020.
[3] Andrew Bryan, Gregory Pepper, Mark H. Wener, Susan L Fink, Chihiro Morishima, Anu Chaudhary,
KeithJerome,PatrickCMathias,andAlexGreninger.Performancecharacteristicsoftheabbottarchitect
sars-cov-2 igg assay and seroprevalence testing in idaho. medRxiv, 2020.
[4] Timothy W Russell, Joel Hellewell, Sam Abbott, CI Jarvis, K van Zandvoort, CMMID nCov working
group, S Flasche, AJ Kucharski, et al. Using a delay-adjusted case fatality ratio to estimate under-
reporting. Centre for Mathematical Modeling of Infectious Diseases Repository, 2020.
[5] Fred S Lu, Andre T Nguyen, Nicholas B Link, Marc Lipsitch, and Mauricio Santillana. Estimating the
early outbreak cumulative incidence of covid-19 in the united states: Three complementary approaches.
medRxiv, 2020.
[6] Justin D. Silverman, Nathaniel Hupert